Sort
23,748 grants matching “melanoma”
Role of inflammation, innate resistance, and immunity in carcinogenesis
$607,045Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Dynamic µOCT for cellular tissue phenotyping
$606,936Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2023 · CA
Non-invasive imaging of the anti-tumor immune response
$606,892Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2021 · CA
Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma
$606,879Levi Alexander Garraway · Massachusetts General Hospital · P01 · FY2014 · CA
Structural and functional characterization of T and NK cell receptors
$606,739Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$606,672David M. Ashley · Duke University · U19 · FY2021 · CA
Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy
$606,635Matthew M. Gubin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy
$606,635Matthew M. Gubin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$606,614James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Gene Therapy for Human Malignant Melanoma
$606,567Introgen Therapeutics, Inc. · R42 · FY2004 · CA
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$606,318Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2012 · CA
Mechanisms of cAMP-dependent regulation of melanosome pH
$606,214Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AR
Mechanisms of cAMP-dependent regulation of melanosome pH
$606,010Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AR
Pathogenesis and Treatment of Kaposiform Lymphangiomatosis
$605,976Timothy David Le Cras · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Background-free molecular imaging using modulated photoacoustics and targeted contrast agent
$605,934Robert M Dickson · Georgia Institute Of Technology · R01 · FY2020 · EB
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$605,710Alejandro V Villagra · Georgetown University · R01 · FY2023 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$605,681John Tanner Wilson · Vanderbilt University · R01 · FY2022 · EB
Applying Genomic Dosimeters of UV Damage to Predicting Skin Cancer Risk
$605,408Douglas E Brash · Yale University · R01 · FY2020 · ES
Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma
$605,352Mihaela Balu · University Of California-Irvine · R01 · FY2023 · CA
Phase III Trial of Selenium for Prostate Cancer Prevention
$605,351Frederick R Ahmann · University Of Arizona · R01 · FY2007 · CA
SUN SAFETY INTERVENTION FOR POSTAL CARRIERS
$605,232San Diego State University · R01 · FY2004 · CA
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
$605,116Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2023 · HL
TISSUE-ENGINEERED CANCER METASTASIS TO IMPROVE THE ABSCOPAL EFFECT AND CANCER IMMUNOTHERAPY IN MELANOMA
$605,018University Of North Carolina At Chapel Hill · · FY2016 · Department of the Army
The Framingham School Nevus Study
$604,934Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · AR
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$604,916University Of Wisconsin Madison · U10 · FY2002 · CA